QurAlis

QurAlis Invited to Present at 43rd Annual J.P. Morgan Healthcare Conference

7 January 2025 -- Massaschusetts, US --  QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative and neurological diseases, today announced that it has been invited to present at the 43rd Annual J.P....
100 Cambridgepark Dr, Cambridge, MA 02140